0001868279 2026-05-11 2026-05-11 0001868279 1 2026-05-11 2026-05-11 iso4217:USD pure S-3 424B5 EX-FILING FEES 333-284661 0001868279 ArriVent BioPharma, Inc. N/A N/A S-3 ArriVent BioPharma, Inc. false Equity Common Stock, $0.0001 par value true 250000000.00 0.0001381 34525.00 250000000.00 34525.00 0.00 0.00 34525.00 In accordance with Rule 457(o) under the Securities Act of 1933, as amended (the "Securities Act"). This "Calculation of Filing Fee Tables" table shall be deemed to update the "Calculation of Registration Fee" table in the registrant's Registration Statement on Form S-3ASR (File No. 333-284661) in accordance with Rule 456(b) and 457(o) under the Securities Act. An indeterminate number of shares of common stock is being registered as may from time to time be offered hereunder at indeterminate prices. The proposed maximum per security and aggregate offering prices per class of securities will be determined from time to time by the registrant in connection with the issuance by the registrant of the securities registered hereunder and is not specified as to each class of security pursuant to General Instruction II.E. of Form S-3 under the Securities Act. Separate consideration may or may not be received for securities that are issuable on exercise, conversion or exchange of other securities, or that are issued in units. 250000000.00 true